Background and Purpose: Drug addiction is a complex disease specified by exacerbation and repetition, uncontrollable penchant, with involuntary seeking for drugs and continuous consumption of that, with its horrible and destructive results. According to the problems which we would be faced with them during drug addiction treatment, this article is going to study on these problems. method: For this study the theoretical foundations and retaining
the existing research literature on the subject was discussed. Results: In this paper, the problems related with addiction treatment, the history of drug addiction treatment, the role of opioid preservative (Methadone and Buprenorphine) and its advantages (such as reducing criminal activities, increasing productivity, improving physical functions, Social and mental health, and limiting the blood-borne pathogens) and the weakness (such as the common side effects of constipation, dizziness, dry mouth, headache, increased transpiration, itching, nausea, sleep problems, and psychiatric disorders) are presented.Conclusion: Although long-term and even short-term addiction prevention and treatment programs will be effective, but the large population of domestic drug users remains a major concern for researchers, their families, therapists, and legal responses. An effective treatment process is one of the major challenges of contemporary research and clinical practice that should help clients to defense with destructive effects of brain addiction and behavior, and regaining control of life and restoring clients to productive functions in the family, workplace and community. addiction treatment using chemical drugs is one of the most difficult, most dangerous, and most responsible drug treatments, and the doctors should also be fully trained in the correct administration of agonist medications, and they must be so patient and educated to their patients.
Key words: Addiction, Pharmacotherapy, Conservative treatment, Treatment problems, The effectiveness of treatment, relapse, prevention
The causes and strategies for suicide prevention: An overview on the theoreti...seyed H
Background and Purpose: Suicide is a major public health problem in all societies, and this phenomenon is rooted in complex behavioral, biological, social and psychological issues, and information in this area can be very effective in preventing. The purpose of this study is to look at empirical theories and research related to the causes of suicide and prevention strategies. method: For this study the theoretical foundations and retaining
the existing research literature on the subject was discussed. Results: Research on suicide has increased in recent years and researchers have used different theoretical models, including socio-cultural, psychological views. Most of the recent research framework developed empirically that the researchers of the causes and risk factors (such as families of disrupted and inefficient, unemployment, frequency of self-injurious behavior, living alone, mental illness, homosexuality and transsexual, physical illness, effort prior to suicide, bereaved and the loss of individual, substance abuse, ideation and suicidal thoughts and planning for it) and prevention strategies (such as the ministers of health, accountability family, job, employment, family support, healthy lifestyle, marital status, physical health, the Positive relationships and social support) in suicidal behavior are revealed. Conclusion: Suicide can be prevented and in order to do this, a better understanding of the causes and risk factors of suicide has to be achieved with respect to genetic, environmental, psychological and social variables, and considering the above mentioned, it developed and implemented specific interventions and interventions. Prevention of suicide is not exclusively a mental health issue, it is a health issue that must be worked on and coordinated at all levels by different groups.
فروشگاه اینترنتی ستارگان اندیشه عرضه کننده محصولات آموزشی و کمک آموزشی فوتبال ، فوتسال و فوتبال ساحلی در ایران و خاور میانه اعم از : سی دی - دی وی دی - کتاب - جزوه و نرم افزار های آنالیز و طراحی تمرین با ارسال رایگان به تمام نقاط ایران با ما تماس بگیرید : 02633554579 - 09125657120 www.andishehstars
The causes and strategies for suicide prevention: An overview on the theoreti...seyed H
Background and Purpose: Suicide is a major public health problem in all societies, and this phenomenon is rooted in complex behavioral, biological, social and psychological issues, and information in this area can be very effective in preventing. The purpose of this study is to look at empirical theories and research related to the causes of suicide and prevention strategies. method: For this study the theoretical foundations and retaining
the existing research literature on the subject was discussed. Results: Research on suicide has increased in recent years and researchers have used different theoretical models, including socio-cultural, psychological views. Most of the recent research framework developed empirically that the researchers of the causes and risk factors (such as families of disrupted and inefficient, unemployment, frequency of self-injurious behavior, living alone, mental illness, homosexuality and transsexual, physical illness, effort prior to suicide, bereaved and the loss of individual, substance abuse, ideation and suicidal thoughts and planning for it) and prevention strategies (such as the ministers of health, accountability family, job, employment, family support, healthy lifestyle, marital status, physical health, the Positive relationships and social support) in suicidal behavior are revealed. Conclusion: Suicide can be prevented and in order to do this, a better understanding of the causes and risk factors of suicide has to be achieved with respect to genetic, environmental, psychological and social variables, and considering the above mentioned, it developed and implemented specific interventions and interventions. Prevention of suicide is not exclusively a mental health issue, it is a health issue that must be worked on and coordinated at all levels by different groups.
فروشگاه اینترنتی ستارگان اندیشه عرضه کننده محصولات آموزشی و کمک آموزشی فوتبال ، فوتسال و فوتبال ساحلی در ایران و خاور میانه اعم از : سی دی - دی وی دی - کتاب - جزوه و نرم افزار های آنالیز و طراحی تمرین با ارسال رایگان به تمام نقاط ایران با ما تماس بگیرید : 02633554579 - 09125657120 www.andishehstars
Mental Health: A Contrastive Analysis between Western and Islamic Psychologie...Mohd Abbas Abdul Razak
The alarming statistics on the many reported cases of mental health in the media has drawn the attention of the researchers towards this area of psychology. Driven by the passion to understand what mental health is, this small scale research is directed towards understanding some of the existing concepts on mental health. Very precisely, it explored the ideas on mental health showcased to the world by Western mainstream psychology, namely; Freudian Psychoanalysis, Radical Behaviourism and Humanistic Psychology. Upon analysing Western concepts on mental health, the researchers ventured on to compare them with ideas presented by Islamic Psychology. It is the contention of the researchers that topics on human nature, mental health and psychotherapy are interrelated and inseparable. As such, any discussion on mental health should also incorporate some ideas on human nature and psychotherapy.
Nuclear medicine is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease. Nuclear medicine, in a sense, is "radiology done inside out" or "endoradiology" because it records radiation emitting from within the body rather than radiation that is generated by external sources like X-rays. In addition, nuclear medicine scans differ from radiology as the emphasis is not on imaging anatomy but the function and for such reason, it is called a physiological imaging modality. Single photon emission computed tomography (SPECT) and positron emission tomography (PET) scans are the two most common imaging modalities in nuclear medicine.
A positron emission tomography (PET) scan is an imaging test that allows your doctor to check for diseases in your body.
The scan uses a special dye containing radioactive tracers. These tracers are either swallowed, inhaled, or injected into a vein in your arm depending on what part of the body is being examined. Certain organs and tissues then absorb the tracer.
When detected by a PET scanner, the tracers help your doctor to see how well your organs and tissues are working.
The tracer will collect in areas of higher chemical activity, which is helpful because certain tissues of the body, and certain diseases, have a higher level of chemical activity. These areas of disease will show up as bright spots on the PET scan.
The PET scan can measure blood flow, oxygen use, how your body uses sugar, and much more.
A PET scan is typically an outpatient procedure. This means you can go about your day after the test is finished.
In the United States, around 2 million PET scans are performed each year.
The evaluation of behavioral disorders in three children with autism spectrum...seyed H
Background and Purpose: Autism is one of 6 neurodegenerative disorders and the main feature of autism spectrum disorder is the continuing deficiency in the creating bilateral communication and social interactions, limited and repeated behavioral patterns, interests, or activities. These symbols are being from early childhood and cause disruption or limitation in daily life. Due to the importance of behavioral disorders in children who are faced with autism, this study was conducted to evaluate these disorders in these children. Methods: This article is based on case-study on three children with autism spectrum disorder in three different severity levels (grade 1, 2, and 3). Results: All three patients had behavioral problems higher than the average; the grade 3 patient had a lot of behavioral problems due to the severity of his illness, and only in the case of anxiety-secretion, he took a lower score, also grade 2 patients has been shown to have behavioral problems due to his age and severity, and only in the social aggression dimension he has scored more than two other patients. The grade 3 patients had less behavioral problems due to his severity of the illness and age, but in case of anxiety – withdrawal he received the highest score and his score was greater than the other two children. Conclusion: Finally, the result of this study highlighted the importance of behavioral disorders in each types of autism spectrum disorders, and it was possible to adopt appropriate approaches to these children at interventional, family and social levels.
زندگی من در مقابل سرطان: خاطرات کلمانتینHooman HAMIDI
در پانزدهم ژوئن 2022، کلمانتین ورنیو،روزنامه نگار رادیوی فرانس اینفو، ناگهان با تشخیصی هولناک روبرو میشود، سرطان مجاری صفراوی. این نوع سرطان، یک بیماری گوارشی نادر و بسیار مهاجم است که زندگی کلمانتین را دگرگون میسازد.
در مجموعه پادکست هایش، کلمانتین شنوندگان را به سفری در اعماق تجربیات خود در مبارزه با این بیماری دشوار میبرد. او با صراحت و شجاعت، از امیدها و تردیدهایش، از سختیها و لحظات طاقتفرسای این مسیر پرفراز و نشیب میگوید.
Mental Health: A Contrastive Analysis between Western and Islamic Psychologie...Mohd Abbas Abdul Razak
The alarming statistics on the many reported cases of mental health in the media has drawn the attention of the researchers towards this area of psychology. Driven by the passion to understand what mental health is, this small scale research is directed towards understanding some of the existing concepts on mental health. Very precisely, it explored the ideas on mental health showcased to the world by Western mainstream psychology, namely; Freudian Psychoanalysis, Radical Behaviourism and Humanistic Psychology. Upon analysing Western concepts on mental health, the researchers ventured on to compare them with ideas presented by Islamic Psychology. It is the contention of the researchers that topics on human nature, mental health and psychotherapy are interrelated and inseparable. As such, any discussion on mental health should also incorporate some ideas on human nature and psychotherapy.
Nuclear medicine is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease. Nuclear medicine, in a sense, is "radiology done inside out" or "endoradiology" because it records radiation emitting from within the body rather than radiation that is generated by external sources like X-rays. In addition, nuclear medicine scans differ from radiology as the emphasis is not on imaging anatomy but the function and for such reason, it is called a physiological imaging modality. Single photon emission computed tomography (SPECT) and positron emission tomography (PET) scans are the two most common imaging modalities in nuclear medicine.
A positron emission tomography (PET) scan is an imaging test that allows your doctor to check for diseases in your body.
The scan uses a special dye containing radioactive tracers. These tracers are either swallowed, inhaled, or injected into a vein in your arm depending on what part of the body is being examined. Certain organs and tissues then absorb the tracer.
When detected by a PET scanner, the tracers help your doctor to see how well your organs and tissues are working.
The tracer will collect in areas of higher chemical activity, which is helpful because certain tissues of the body, and certain diseases, have a higher level of chemical activity. These areas of disease will show up as bright spots on the PET scan.
The PET scan can measure blood flow, oxygen use, how your body uses sugar, and much more.
A PET scan is typically an outpatient procedure. This means you can go about your day after the test is finished.
In the United States, around 2 million PET scans are performed each year.
The evaluation of behavioral disorders in three children with autism spectrum...seyed H
Background and Purpose: Autism is one of 6 neurodegenerative disorders and the main feature of autism spectrum disorder is the continuing deficiency in the creating bilateral communication and social interactions, limited and repeated behavioral patterns, interests, or activities. These symbols are being from early childhood and cause disruption or limitation in daily life. Due to the importance of behavioral disorders in children who are faced with autism, this study was conducted to evaluate these disorders in these children. Methods: This article is based on case-study on three children with autism spectrum disorder in three different severity levels (grade 1, 2, and 3). Results: All three patients had behavioral problems higher than the average; the grade 3 patient had a lot of behavioral problems due to the severity of his illness, and only in the case of anxiety-secretion, he took a lower score, also grade 2 patients has been shown to have behavioral problems due to his age and severity, and only in the social aggression dimension he has scored more than two other patients. The grade 3 patients had less behavioral problems due to his severity of the illness and age, but in case of anxiety – withdrawal he received the highest score and his score was greater than the other two children. Conclusion: Finally, the result of this study highlighted the importance of behavioral disorders in each types of autism spectrum disorders, and it was possible to adopt appropriate approaches to these children at interventional, family and social levels.
زندگی من در مقابل سرطان: خاطرات کلمانتینHooman HAMIDI
در پانزدهم ژوئن 2022، کلمانتین ورنیو،روزنامه نگار رادیوی فرانس اینفو، ناگهان با تشخیصی هولناک روبرو میشود، سرطان مجاری صفراوی. این نوع سرطان، یک بیماری گوارشی نادر و بسیار مهاجم است که زندگی کلمانتین را دگرگون میسازد.
در مجموعه پادکست هایش، کلمانتین شنوندگان را به سفری در اعماق تجربیات خود در مبارزه با این بیماری دشوار میبرد. او با صراحت و شجاعت، از امیدها و تردیدهایش، از سختیها و لحظات طاقتفرسای این مسیر پرفراز و نشیب میگوید.
Problems and Issues Facing Pharmacotherapy of Addiction
1. www.PSYCHOconf.ir1
Problems and Issues Facing Pharmacotherapy of Addiction
SG. Seyed Hashemi1
, F. Haghighati2
, H. Kord3
1- MSc in Psychology, Faculty of Psychology and Educational Sciences, Azarbaijan Shahid Madani
University, Tabriz, Iran (Corresponding Author): Tel: 09147270904, E-Mail:
seyedhashemi@azaruniv.ac.ir
2 & 3- MSc in Psychology, Faculty of Psychology and Educational Sciences, Azarbaijan Shahid
Madani University, Tabriz, Iran
Abstract
Background and Purpose: Drug addiction is a complex disease specified
by exacerbation and repetition, uncontrollable penchant, with involuntary
seeking for drugs and continuous consumption of that, with its horrible and
destructive results. According to the problems which we would be faced
with them during drug addiction treatment, this article is going to study on
these problems. method: For this study the theoretical foundations and
retaining the existing research literature on the subject was discussed.
Results: In this paper, the problems related with addiction treatment, the
history of drug addiction treatment, the role of opioid preservative
(Methadone and Buprenorphine) and its advantages (such as reducing
criminal activities, increasing productivity, improving physical functions,
Social and mental health, and limiting the blood-borne pathogens) and the
weakness (such as the common side effects of constipation, dizziness, dry
mouth, headache, increased transpiration, itching, nausea, sleep problems,
and psychiatric disorders) are presented. Conclusion: Although long-term
and even short-term addiction prevention and treatment programs will be
effective, but the large population of domestic drug users remains a major
concern for researchers, their families, therapists, and legal responses. An
effective treatment process is one of the major challenges of contemporary
research and clinical practice that should help clients to defense with
destructive effects of brain addiction and behavior, and regaining control of
life and restoring clients to productive functions in the family, workplace
and community. addiction treatment using chemical drugs is one of the most
difficult, most dangerous, and most responsible drug treatments, and the
doctors should also be fully trained in the correct administration of agonist
medications, and they must be so patient and educated to their patients.
Keywords: Addiction, Pharmacotherapy, Conservative treatment,
Treatment problems, The effectiveness of treatment, relapse, prevention
10. www.PSYCHOconf.ir10
خطرن ،ها آن از مواد ی کننده مصرف سوء بیمارواسطه به بیماران از دسته این دیگر سوی از .است کشنده حتی و اک
نحوه و دارو از مراقبت در ،بیماری این های ویژگیپیامدهای رخداد احتمال و ندارند کافی دقت آن مصرف صحیح ی
است مواد مصرف سوء و درمان مراکز مدیریتی و پزشکی های دغدغه ترین مهم از دیگر یکی قانونی و پزشکینیز پزشکان .
بیماران به حوصله با و بیاموزند کامل طور به را آگونیستی داروهای تجویز صحیح ی نحوه زمینه در الزم های آموزش باید
سطح سو یک از که باید نیز اعتیاد پذیری بازگشت ویژگی با رابطه در .دهند قرار پایش مورد را آن و داده آموزش خود
واق به را ها خانواده توقع،غیردارویی و دارویی ای چندجانبه های درمان ی ارایه با دیگر سوی از و کند نزدیک موجود عیت
ارائه و پایین دوزهای تجویز با افیونی غیر های دارو به وابستگی از امکان حد تا و .برسانند حداقل به را بازگشت امکان
[کنند پیشگیری غیردارویی راهکارهای81-82.]
References
1.Naderi, N., Binazadeh, M., Sefatian, S., & Asghar Peyvandi, A. (2009). Comprehensive
text book of addiction: Dependence to different substances and their pharmacological and
non-pharmacological treatment. Tehran, Iran: Drug Control Headquarters.
2.Flura K & Stalikas A (2013) Factors affecting substance abuse treatment across different
treatment phases. International Journal of Psychosocial Rehabilitation, 17(1), 89-104.
3.West, R., Hardy, A. (2005) Theory of addiction. Oxford. Blackwell Publishing Ltd.
4. Mokri, A. (2002). Brief overview of the status of drug abuse in Iran. Archives of Iranian
Medicine, 5(3), 184-90.
5. De Kort, G., Vazirian, M., & Nassirimanesh, B. (2006). Young people and drugs–
Towards a comprehensive health promotion policy–Tehran report. Asian Harm Reduction
Network (AHRN) Final Report.
6.World Health Organization. (2009). Guidelines for the psychosocially assisted
pharmacological treatment of opioid dependence. Geneva, Switzerland: Author.
7. Stein, D., Lerer, B., & Stahl, S. M. (Eds.). (2012). Essential evidence-based
psychopharmacology (2nd ed.). Cambridge; New York: Cambridge University Press.
8. Flora, K., & Stalikas, A. (2013) Factors affecting substance abuse treatment across
different treatment phases. International Journal of Psychosocial Rehabilitation, 17(1), 89-
104.
9.DiClemente, C.C. & Scott, C.W. (1997). Stages of change: interaction with treatment
compliance and involvement. In L.S. Onken, J.D. Blaine, & J.J.Boren, (eds.), Beyond the
Therapeutic Alliance: Keeping the Drug-Dependent Individual in Treatment. Rockville,
MD: National Institute on Drug Abuse.
10. Long, C. G., Hollin, C. R., & Williams, M. J. (1998). Self-efficacy, outcome
expectations, and fantasies as predictors of alcoholics' posttreatment drinking. Substance
use & misuse, 33(12), 2383-2402.
11.Izquierdo, F. M., de Osma, F. J., Arnedillo, J. J., Cotaberria, A.M. (2001). Self-concept,
self-esteem, locus of control and self-efficacy in alcohol dependence. [Spanish]. Anales de
Psiquiatria, 17(4),153-161.
11. www.PSYCHOconf.ir11
12.Burleson, J.A., Kaminer, Y., (2005). Self-efficacy as a predictor of treatment outcome
in adolescent substance use disorders. Addictive Behaviors, 30(9), 1751-1764.
13.Ilgen, M., McKellar, J., & Moos, R. (2007). Personal and treatment-related predictors of
abstinence self-efficacy. Journal of Studies on Alcohol and Drugs, 68(1), 126-132.
14. Solomon, K. E., & Annis, H. M. (1990). Outcome and efficacy expectancy in the
prediction of post‐treatment drinking behaviour. Addiction, 85(5), 659-665.
15.Colon, I. & Massey, R.K. (1988). Patient attitudes and beliefs as predictors of treatment
outcome in detoxification: A pilot study. Alcoholism Treatment Quarterly, 5(3-4), 235-
244.
16.Dearing, R.L., Barrick, C., Dermen, K.H. & Walitzer, K. S. (2005). Indicators of Client
Engagement: Influences on Alcohol Treatment Satisfaction and Outcomes. Psychology of
Addictive Behaviors, 19(1), 71-78.
17.Joe, G.W., Flynn, P.M., Broome, K.M. & Simpson, D.D. (2007). Pattern of drug use
and expectations in methadone patients. Addictive behaviours, 32(8), 1640-1656.
18.Joyce, Α.S. & Pipper, W.E. (1998). Expectancy, the therapeutic alliance, and treatment
outcome in short-term individual psychotherapy. Journal of Psychotherapy Practice &
Research. 7(3), 236-248.
19. Kreek, M. J. (2000). Methadone‐Related Opioid Agonist Pharmacotherapy for Heroin
Addiction: History, Recent Molecular and Neurochemical Research and Future in
Mainstream Medicine. Annals of the New York Academy of Sciences, 909(1), 186-216.
20. US Department of Health and Human Services. (2002). Substance Abuse and Mental
Health Services Administration. (2003). A national call to action: Eliminating the use of
seclusion and restraint.
21. Soyka, M., Kranzler, H. R., Berglund, M., Gorelick, D., Hesselbrock, V., Johnson, B.
A., ... & Berglund, M. (2008). World Federation of Societies of Biological Psychiatry
(WFSBP) guidelines for biological treatment of substance use and related disorders, part 1:
alcoholism. The World Journal of Biological Psychiatry, 9(1), 6-23.
22. Soyka, M., Kranzler, H. R., van den Brink, W., Krystal, J., Möller, H. J., & Kasper, S.
(2011). The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines
for the biological treatment of substance use and related disorders. Part 2: Opioid
dependence. The world journal of biological psychiatry, 12(3), 160-187.
23. Snyder, J. L., & Bowers, T. G. (2008). The efficacy of acamprosate and naltrexone in
the treatment of alcohol dependence: a relative benefits analysis of randomized controlled
trials. The American journal of drug and alcohol abuse, 34(4), 449-461.
24. Streeton, C., & Whelan, G. (2001). Naltrexone, a relapse prevention maintenance
treatment of alcohol dependence: a meta-analysis of randomized controlled trials. Alcohol
and Alcoholism, 36(6), 544-552.
25. Boothby, L. A., & Doering, P. L. (2005). Acamprosate for the treatment of alcohol
dependence. Clinical therapeutics, 27(6), 695-714.
12. www.PSYCHOconf.ir12
26.Mattick, R., Kimber, J., Breen, C., Davoli, M. (2008) Buprenorphine maintenance
versus placebo or methadone maintenance for opioid dependence. The Cochrane Database
of Systematic Reviews, 16 (2), CD002207.
27.Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance
therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database
of Systematic Reviews, 3, 1–31.
28.Barnett PG. (2009) Comparison of costs and utilization among buprenorphine and
methadone patients. Addiction, 104(6), 982–92.
29.Barnett PG, Zaric GS, Brandeau ML. (2001) The cost-effectiveness of buprenorphine
maintenance therapy for opiate addiction in the United States. Addiction, 96(9), 1267–78.
30.Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R. J., & Taylor,
R. S. (2007). Methadone and buprenorphine for the management of opioid dependence: A
systematic review and economic evaluation. Health Technology Assessment, 11, 1–171.
31.McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. (2005) Reconsidering the
evaluation of addiction treatment: from retrospective follow-up to concurrent recovery
monitoring. Addiction 100(4), 447-58.
32. Dole, V. P., & Nyswander, M. (1965). A medical treatment for diacetylmorphine
(heroin) addiction: a clinical trial with methadone hydrochloride. Jama, 193(8), 646-650.
33.Ward, J., W. Hall and R.P. Mattick. (1999) Role of maintenance treatment in opioid
dependence. Lancet, 353, 221–226.
34.Fareed, A., Casarella, J., Amar, R., Vayalapalli, S., & Drexler, K. (2010). Methadone
maintenance dosing guideline for opioid dependence—A literature review. Journal of
Addictive Diseases, 29(1), 1–14.
35.Marsch, L. A. (1998). The efficacy of methadone maintenance interventions in reducing
illicit opiate use, HIV risk behavior and criminality: A meta-analysis. Addiction, 93, 515–
532.
36.Bloor, M., J. McIntosh, N. McKeganey and M. Robertson. (2008) ‘Topping up’
methadone: an analysis of patterns of heroin use among a treatment sample of Scottish
drug users. Public Health, 122, 1013–1019.
37.Brady, T. M., Salvucci, S., Sverdlov, L. S., Male, A., Kyeyune, H., Sikali, E., et al.
(2005). Methadone dosage and retention: an examination of the 60 mg/day threshold.
Journal of Addictive Diseases, 24(3), 23–47.
38.Donny, E. C., Brasser, S. M., Bigelow, G. E., Stitzer, M. L., & Walsh, S. L. (2005).
Methadone doses of 100 mg or greater are more effective than lower doses at suppressing
heroin self-administration in opioid-dependent volunteers. Addiction, 100(10), 1496–1509.
39.Rounsaville, B. J., & Kleber, H. D. (1985). Untreated opiate addicts: how do they differ
from those seeking treatment?. Archives of General Psychiatry, 42(11), 1072-1077.
40.Gerstein, D. R., & Lewin, L. S. (1990). Treating drug problems. New England Journal
of Medicine, 323(12), 844-848.
41.Ward, J., W. Hall and R.P. Mattick. (1999) Role of maintenance treatment in opioid
dependence. Lancet, 353, 221–226.
13. www.PSYCHOconf.ir13
42.Stein, M. D., Herman, D. S., Bishop, S., Lassor, J. A., Weinstock, M., Anthony, J., &
Anderson, B. J. (2004). Sleep disturbances among methadone maintained patients. Journal
of substance abuse treatment, 26(3), 175-180.
43.Peles, E., S. Schreiber and M. Adelson. (2006) Variables associated with perceived
sleep disorders in methadone maintenance treatment (MMT) patients. Drug Alcohol
Depend. 82, 103–110.
44.Wang, W., Li, Q., Wang, Y., Tian, J., Yang, W., Li, W., ... & Liu, J. (2011). Brain
fMRI and craving response to heroin-related cues in patients on methadone maintenance
treatment. The American journal of drug and alcohol abuse, 37(2), 123-130.
45.Verdejo, A., Toribio, I., Orozco, C., Puente, K. L., & Pérez-García, M. (2005).
Neuropsychological functioning in methadone maintenance patients versus abstinent
heroin abusers. Drug and alcohol dependence, 78(3), 283-288.
46.Fudala, P. J., Bridge, T. P., Herbert, S., Chiang, C. N., & Leiderman, D. B. (1998). A
multisite efficacy evaluation of a buprenorphine/naloxone product for opiate dependence
treatment. NIDA Research Monograph, 179, 105.
47. Obadia, Y., Perrin, V., Feroni, I., Vlahov, D., & Moatti, J. P. (2001). Injecting misuse
of buprenorphine among French drug users. Addiction, 96(2), 267-272.
48.Walsh SL, Preston KL, Bigelow GE, Stitzer ML. (1995) Acute administration of
buprenorphine in humans: partial agonist and blockade effects. The Journal of
pharmacology and experimental therapeutics, 274(1), 361–72.
49.Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE. (1994) Clinical
pharmacology of buprenorphine: ceiling effects at high doses. Clinical pharmacology and
therapeutics, 55(5), 569–80.
50.Kakko, J., Svanborg, K. D., Kreek, M. J., & Heilig, M. (2003). 1-year retention and
social function after buprenorphine-assisted relapse prevention treatment for heroin
dependence in Sweden: a randomised, placebo-controlled trial. The Lancet, 361(9358),
662-668.
51.Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., ... &
Ling, W. (2003). Office-based treatment of opiate addiction with a sublingual-tablet
formulation of buprenorphine and naloxone. New England Journal of Medicine, 349(10),
949-958.
52.Johnson RE, Eissenberg T, Stitzer ML, Strain EC, Liebson IA, Bigelow GE. (1995) A
placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence.
Drug and alcohol dependence, 40(1), 17–25.
53. Long, C. G., Hollin, C. R., & Williams, M. J. (1998). Self-efficacy, outcome
expectations, and fantasies as predictors of alcoholics' posttreatment drinking. Substance
use & misuse, 33(12), 2383-2402.
54. Kosten, T. R., Schottenfeld, R., Ziedonis, D., & Falcioni, J. (1993). Buprenorphine
versus methadone maintenance for opioid dependence. The Journal of nervous and mental
disease, 181(6), 358-364.
55.،اسدافروزتقی محمد(1387شیراز .مخدر وترکمواد اعتیاد یابی ریشه .):.مهر کوشاه انتشارات
14. www.PSYCHOconf.ir14
56.McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. (2005) Reconsidering the
evaluation of addiction treatment: from retrospective follow-up to concurrent recovery
monitoring. Addiction 100(4),447-58.
57.Emrick, C. D. (1975). A review of psychologically oriented treatments for alcoholism
II. The relative effectiveness of different treatment approaches and the effectiveness of
treatment versus no treatment. Journal of Studies on Alcohol, 36, 88–108.
58.Armor, D. J., Polich, J. M. & Stambul, H. B. (1976). Alcoholism and Treatment. Santa
Monica, CA: RAND Corporation Press. In: Ball, J. C. & Ross, A. (1991) The Effectiveness
of Methadone Maintenance Treatment. New York: Springer-Verlag.
59. Hubbard, R. L., Marsden, M. E., Rachal, J. V., Harwood, H. J., Cavanaugh, E. R., &
Ginzburg, H. M. (1989). Drug abuse treatment: A national study of effectiveness.
University of North Carolina Press.
60. Gerstein, D. R., & Lewin, L. S. (1990). Treating drug problems. New England Journal
of Medicine, 323(12), 844-848.
61.Ball J. C. & Ross, A. (1991). The Effectiveness of Methadone Maintenance Treatment.
New York: Springer-Verlag.
62.McLellan, A. T., Grissom, G., Alterman, A. I., Brill, P. & O’Brien, C. P. (1993)
Substance abuse treatment in the private setting: are some programs more effective than
others? Journal of Substance Abuse Treatment, 10, 243–254.
63.Finney, J. W., Hahn, A. C. & Moos, R. H. (1996) The effectiveness of in-patient and
out-patient treatment for alcohol abuse: the need to focus on mediators and moderators of
setting effects. Addiction, 91, 1773–1796.
64.Simpson, D. D., Joe, G. W. & Brown, B. S. (1997) Treatment retention and follow-up
outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of
Addictive Behaviors, 11, 294–301.
65.Hyman, S. E., & Malenka, R. C. (2001). Addiction and the brain: The neurobiology of
compulsion and its persistence. Nature Reviews Neuroscience, 2, 695–703.
66.McLellan, A. T., Lewis, D. C., O’Brien, C. P., & Kleber, H. D. (2000). Drug
dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes
evaluation. Journal of the American Medical Association, 284, 1689–1695.
67.Nicholls, L., Bragaw, L., & Ruetsch, C. (2010). Opioid dependence treatment and
guidelines. Journal of Managed Care Pharmacy, 16(1), 14-21.
68.Courtwright, D. (1982). Dark paradise: Opiate addiction in America before 1940.
Cambridge, MA: Harvard University Press.
69.Dole, V.P., Robinson, J. W., Orraca, J., Towns, E., Searcy, P., & Caine, E. (1969).
Methadone treatment of randomly selected criminal addicts. New England Journal of
Medicine, 280, 1372–1375.
70. Massing, M. (2000). The fix. Univ of California Press.
71.Hedrich, D., Alves, P., Farrell, M., Stover, H., Moller, L., & Mayet, S. (2012). The
effectiveness of opioid maintenance treatment in prison settings: A systematic review.
Addiction, 107, 501–517.
15. www.PSYCHOconf.ir15
72.Ward, J., W. Hall and R.P. Mattick. (1999) Role of maintenance treatment in opioid
dependence. Lancet, 353, 221–226.
73.Kinlock, T. W., Gordon, M. S., Schwartz, R. P., Fitzgerald, T. T., & O’Grady, K. E.
(2009). Randomized clinical trial of methadone maintenance for prisoners: Results at
twelve months' post-release. Journal of Substance Abuse Treatment, 37, 277–285.
74.Gordon, M. S., Kinlock, T. W., Schwartz, R. P., & O’Grady, K. E. (2008). A
randomized clinical trial of methadone maintenance for prisoners: Findings at 6 months'
post-release. Addiction, 103, 1333–1342.
75.Miller, W. R. & Hester, R. K. (1986). The effectiveness of alcoholism treatment
methods: what research reveals. In: Miller, W. R. & Heather, N., eds. Treating Addictive
Behaviors: Process of Change, pp. 112–134. New York: Plenum Press.
76.Institute of Medicine (1998) Bridging the Gap Between Practice and Research:
Forging Partnerships with Community-Based Drug and Alcohol Treatment. Washington,
DC: National Academy Press.
77.Unt, W. A., Barnett, L. W. & Branch, L. G. (1971) Relapse rates in addiction programs.
Journal of Clinical Psychology, 27, 455– 456.
78.Hubbard, R. L., Marsden, M. E., Rachal, J. V., Harwood, H. J., Cavanaugh, E. R. &
Ginzburg, H. M. (1989) Drug Abuse Treatment: A National Study of Effectiveness. Chapel
Hill, NC: University of North Carolina Press.
79.Hser, Y., Anglin, M. D., Grella, C., Longshore, D. & Prendergast, M. L. (1997) Drug
treatment careers: a conceptual framework and existing research findings. Journal of
Substance Abuse Treatment, 14, 543–558.
80.Hser, Y., Anglin, M. D., Grella, C., Longshore, D. & Prendergast, M. L. (1997) Drug
treatment careers: a conceptual framework and existing research findings. Journal of
Substance Abuse Treatment, 14, 543–558.
81.McKay, J. R., Lynch, K. G., Shepard, D. S., Ratichek, S., Morrison, R., Koppenhaver,
J. & Pettinati, H. M. (2004) The effectiveness of telephone-based continuing care in the
clinical management of alcohol and cocaine use disorders: 12 month outcomes. Journal of
Consulting and Clinical Psychology. 72, 969– 979.
82.Ind B, Chen S,Weatherburn D, Mattick R (2005).The effectiveness of methadone
maintenance treatment in controlling crime. An Australian aggregate-level analysis.
Journal of Criminology 45, 201–211.
83.Hser YI, Saxon AJ, Huang D, et al (2013) Treatment retention among patients
randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.
Addiction, 109, 79–87.
84.ll J, Trinh L, Butler B, Randall D, Rubin G (2009a). Comparing retention in treatment
and mortality in people after initial entry to methadone and buprenorphine treatment.
Addiction, 104, 1193–1200.
85.Bell JR, Butler B, Lawrance A, Batey R, Salmelainen P (2009b). Comparing overdose
mortality associated with methadone and buprenorphine treatment. Drug and Alcohol
Dependence 104, 73–77.
16. www.PSYCHOconf.ir16
86.Mitchell T B, White J M, Somogyi A A, & Bochner F, (2004) Slow-release oral
morphine versus methadone: a crossover comparison of patient outcomes and acceptability
as maintenance pharmacotherapies for opioid dependence. Addiction, 99(8), 940-945.
87.Eder H, Jagsch R, Kraigher D, et al (2005) Comparative study of the effectiveness of
slow-release morphine and methadone for opioid maintenance therapy. Addiction, 100,
1101–9.